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ABSTRACT: Development of an oral in vivo predictive dissolution medium for acid drugs with a pKa in the physiological range (e.g.,
Biopharmaceutics Classification System Class IIa) requires transport analysis of the complex in vivo CO2/bicarbonate buffering system. In
this report, we analyze this buffer system using hydrodynamically defined rotating disk dissolution. Transport analysis of drug flux was
predicted using the film model approach of Mooney et al1 based on equilibrium assumptions as well as accounting for the slow hydration
reaction, CO2 + H2O → H2CO3. The accuracy of the models was compared with experimentally determined results using the rotating
disk dissolution of ibuprofen, indomethacin, and ketoprofen. The equilibrium and slow hydration reaction rate models predict significantly
different dissolution rates. The experimental results are more accurately predicted by accounting for the slow hydration reaction under a
variety of pH and hydrodynamic conditions. Although the complex bicarbonate buffering system requires further consideration given its
dynamic nature in vivo, a simplifying irreversible reaction (IRR) transport analysis accurately predicts in vitro rotating disk dissolution rates of
several carboxylic acid drugs. This IRR transport model provides further insight into bicarbonate buffer and can be useful in developing more
physiologically relevant buffer systems for dissolution testing. C© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J
Pharm Sci 103:3473–3490, 2014
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INTRODUCTION
When a drug product is administered orally, the absorption
may be limited by the rate at which the drug dissolves in
the gastrointestinal tract. For Biopharmaceutics Classification
SystemClass II low solubility drugs, dissolution can be the rate-
limiting step.2 The composition of the intestinal fluid plays a
critical role in determining this rate. One of the main compo-
nents of intestinal fluid is the bicarbonate buffer species that
controls lumenal pH. Buffers can have a large effect on the
dissolution of ionizable drugs by affecting the pH at the solid
liquid interface (surface) of the dissolving drug.1,3–6
Bicarbonate (HCO3−) is secreted by epithelial cells and the
pancreas into the small intestine where it is the main buffer
in the lumen and acts to maintain a relatively constant pH in
the intestinal tract. Bicarbonate is thought to follow the Jacobs
Stewart Cycle in the small intestine.7–9 Bicarbonate (HCO3−)
present in the intestinal lumen can react with hydrogen ions
(H+) to form carbonic acid (H2CO3), which then produces car-
bon dioxide [CO2(aq)] and water (H2O) through the dehydra-
tion reaction. This process is reversible (see Reaction 2 below)
and carbon dioxide can diffuse into the intestinal cells or react
with water to form carbonic acid through the hydration reac-
tion. Carbonic acid can also ionize to form hydrogen ions and
bicarbonate. In the intestinal cells, the same reversible process
can occur, resulting in the formation of CO2 (aq) and HCO3−.
The HCO3− formed in the intestinal cells can be transported
back into the intestinal lumen. The concentration of each of the
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species formed is dependent on the corresponding equilibrium
constants.
Concentrations of aqueous carbon dioxide and bicarbonate
are directly related in the luminal fluid of the GI tract.10–12
In the stomach of healthy humans, the percent CO2 typically
ranges between 4% and 10% CO2 (30–76 mmHg) and similar
values are observed in the proximal jejunum.12,13 McGeese and
Hastingsmeasured an average of 13.2% (100mmHg) CO2 in the
jejunum at an average pH of 6.5.14 In the proximal duodenum,
where there is a lower pH, these values are typically signifi-
cantly higher and can be as high as 66% CO2 (500 mmHg).15
These %CO2 levels can be compared with normal atmospheric
conditions, which are approximately 0.04%. The stomach se-
cretes about 400 mmol of H+ per day9 (17 mmol/h), which en-
ters the duodenum. Therefore, bicarbonate must be secreted at
a rate in the duodenum that is high enough to neutralize the
incoming H+. This increase in bicarbonate and H+ will result in
an increase in the concentration of CO2 partial pressure in the
duodenum. Bicarbonate secretions have been shown to range
from approximately 150–600 :mol cm−1 h−1 (∼6mmol/h) in the
proximal duodenum to approximately 25–200 :mol cm−1 h−1
(∼2 mmol/h) in the distal duodenum depending on the H+
concentration.11 The differences in the H+ stomach secretions
and duodenal bicarbonate secretions results in the pH of the
proximal duodenum fluctuating up to 5 pH units transiently.9
An important consideration in more fully understanding the
bicarbonate system are the individual reaction rates associated
with the equilibrium constants Kc and Ka1 in Reaction 2 below.
In particular, the hydration and dehydration reactions associ-
ated with Kc are six to 10 orders of magnitude slower than the
reaction rates associated with Ka1. The enzyme carbonic an-
hydrase is present in the intracellular fluid and membranes
of the epithelial cells of the intestinal tract.8,16 It functions
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to significantly accelerate the hydration and dehydration re-
actions in these regions. However, there is no evidence that
carbonic anhydrase is secreted or present in the luminal fluid.
Therefore, it is likely that the hydration and dehydration reac-
tions occur at their slow rates in the bulk lumenal fluid.
Understanding the role of bicarbonate buffer and the reac-
tions involved in its formation is essential to understanding the
dissolution of weak acid and weak base drugs in the intestinal
tract and, ultimately, to creating a more physiologically rel-
evant dissolution medium. Although the impact that buffers
have on a dissolving drug has been modeled accurately and is
well understood, there has been little consideration of the effect
of bicarbonate buffer on drug dissolution in the intestine.1,3–6
There have been several studies characterizing the effect bicar-
bonate buffer has on drug dissolution and attempts have been
made at modeling the process.5,10,17–19 However, a thorough ex-
amination of how the CO2 reaction chemistry of bicarbonate
buffer affects drug dissolution has not been explored, although
this is an area that has been studied rigorously and applied in
geology and other sciences.20–24 It is anticipated that a better
understanding of the impact of bicarbonate buffer on the pH at
the surface of a dissolving ionizable drug will provide the foun-
dation for creating buffer systems that more closely resemble
in vivo conditions and dissolution.
The significant role the slow hydration and dehydration
rates have on the formation of bicarbonate and its ability to
function as a buffer and alter the pH at the surface of dissolving
drug (i.e., at the solid liquid interface) has been investigated in
this study. The simultaneous convective diffusion and chemical
reaction within the boundary layer model assuming either: (a)
instantaneous chemical equilibrium, or (b) slow hydration and
dehydration will be compared with experimental results us-
ing the defined hydrodynamics of the rotating disk dissolution
system for weak acid drugs. Our analysis and experimental re-
sults demonstrate that the slow irreversible reaction rate (IRR)
model best matches the experimental rotating disk dissolution
rate of the weak acid drugs studied. This analysis can be helpful
in developing buffering systems that are more physiologically
relevant for in vivo dissolution predictions and testing. A simi-
lar analysis may be applied to weak base and amphoteric drugs.
We have successfully applied this approach to weak base drugs
and is the subject of a future publication.
Reactions and Kinetics of the Bicarbonate Buffer System
Conversion of CO2(g) to CO2(aq)
Bicarbonate buffer can be produced experimentally by control-
ling the partial pressure of CO2 (g) equilibrated with water as
shown in reactions 1 and 2.
CO2(g)
KH
CO2 (aq) (Reaction 1)
CO2 (aq)+H2O
Kc
H2CO3
Kal
H+ +HCO−3 (Reaction 2)
The concentration of carbon dioxide dissolved in water,
CO2 (aq), follows Henry’s Law constant (KH) and the partial
pressure of carbon dioxide gas [PCO2(g)].
KH = CO2 (aq)PCO2 (g)
(1)
Table 1. Measured Values from Literature and Estimated Values of
Henry’s Law Constant for Carbon Dioxide at Different Temperature
and Ionic Strength
Solvent Temperature (◦C) Henry’s Law Constant
Water 35 0.027 (Ref. 26)
Water 40 0.024 (Ref. 26)
0.2 M NaCl Solution 35 0.026 (Ref. 26)
0.2 M NaCl Solution 40 0.023 (Ref. 26)
Isotonic solution (0.0154 M) 37 0.024a
aEstimated using the van’t Hoff Equation for temperature dependence and
ionic strength dependence from Butler.25
The solubility of carbon dioxide in water decreases as the
temperature and ionic strength increases25 and KH may be ad-
justed to account for physiologically relevant conditions (37◦C,
isotonic solution, KH = 0.024). This value is in close agreement
with experimental values shown in Table 1.
The Reversible Reaction Between CO2(aq) and H2O(1) to Form
H2CO3 (Hydration and Dehydration Reactions)
Reaction 2 is composed of two separate steps and the equilib-
rium constants of each reaction (Kc and Ka1) govern the overall
reaction. The reaction of CO2 (aq) with water to form H2CO3 is
given by:
CO2 (aq)+H2O
Kc→←H2CO3 (Reaction 3)
The value for Kc is equal to the ratio for the hydration rate
of CO2 (aq) and the dehydration rate of H2CO3.
Kc = khkd (2)
Kc =
[
H2CO3
]
[
CO2 (aq)
] (3)
The hydration (kh) and dehydration rate constants (kd) vary
with temperature and ionic strength. Values obtained experi-
mentally in the range of 30◦C–40◦C are shown in Table 2. The
reaction rate values are approximately ∼0.1–0.16 s−1 for the
hydration rate and ∼50–80 s−1 for the dehydration rate. These
reactions rates are very slow (e.g., 106 to 1010 times slower)
relative to typical ionization reaction rates that are considered
to be instantaneous as discussed below.
The Reversible Ionization of H2CO3 to form HCO3− and H+
The value for Ka1 shown in Reaction 2 is composed of the for-
ward reaction rate (ka1f ) for the ionization of carbonic acid to
form HCO3− and H+ and the reverse reaction rate (ka1r) where
HCO3− reacts with H+ to form H2CO3.
H2CO3
Kal
H+ +HCO−3 (Reaction 4)
Ka1 = ka1fka1r (4)
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Table 2. Experimental Values from Literature Obtained for the Hydration and Dehydration Rate Constant of Carbonic Acid, Carbon Dioxide,
and Water
Temperature (◦C) Solvent Kh (s−1) Kd (s−1)
38 Buffer mixture with gaseous CO2 0.161 (Ref. 27)
40 Water 0.143 (Ref. 28)
38 Phosphate buffer 0.062 (Ref. 29)
37 Imidazole buffer with CO2 gas or sodium bicarbonate 0.145 (Ref. 30) 49.5 (Ref. 30)
32.5 HCl and sodium bicarbonate mixture (made to ionic strength of 0.65 with NaCl) 0.057 (Ref. 31) 50.2 (Ref. 31)
36.7 HCl and sodium bicarbonate mixture 80 (Ref. 32)
36.9 HCl and sodium bicarbonate mixture 49.04 (Ref. 33)
37 HCl and potassium bicarbonate mixture (0.1 M ionic strength) 72 (Ref. 34)
Ka1 =
[
H+
] [
HCO−3
]
[
H2CO3
] (5)
The value of Ka1 depends on temperature and ionic strength.
Table 3 presents experimental values of pKa ∼ 3.55 reported at
approximately 37◦C. Information regarding exact values for the
forward and reverse ionization rates at 37◦C is limited. How-
ever, values for the reaction rate constants determined by Eigen
and Hammes35 at 25◦Cwere s−1 and ka1r = 4.7× 1010s−1. These
values are 6–10 orders of magnitude greater than the hydration
(kh) and dehydration rate (kd) constants described above. It can
be assumed that Reaction 4 occurs instantaneously compared
with rates of diffusion.
The Overall Equilibrium Reaction Constant Ka
It is often assumed that the entire reaction (Reaction 2) is at
equilibrium where Kc and Ka1 are combined to give an overall
Ka value (Eqs. (6a) and (6b)) and Reaction 2 is simplified to
Reaction 5.
CO2 +H2O
Ka
HCO−3 +H+ (Reaction 5)
Ka =
[
H2CO3
]
[
CO2 (aq)
] ·
[
H+
] [
HCO−3
]
[
H2CO3
] =
[
H+
] [
HCO−3
]
[
CO2 (aq)
] (6a)
Ka =
[
H+
] [
HCO−3
]
[
CO2 (aq)
] (6b)
Ka has been determined at different temperatures and ionic
strengths to be pKa ∼6. Using experimentally obtained data as
shown in Table 4, it is possible to adjust Ka based on tempera-
ture and ionic strength.
When assuming equilibrium, Eq. (6b) can be rearranged to
calculate the bicarbonate concentration in solution as a func-
tion of dissolved carbon dioxide [CO2(aq)] and pH:
[
HCO−3
] = Ka
[
CO2 (aq)
]
[
H+
] (7)
Alternatively, this can be written as a function of the par-
tial pressure of carbon dioxide (PCO2 ) using KH, assuming
Table 3. Experimental Values from Literature Obtained at Different Experimental Conditions for the Equilibrium Constant Ka1 (Ratio of the
Forward and Reverse Ionization Reaction)
Temperature (◦C) Solvent Ka1 pKa1
35 Buffer with NaCl (ionic strength = 0.143) 2.816× 10−4 (Ref. 36) 3.55
35 Aqueous solution 1.67× 10−4 (Ref. 37) 3.78
38 Aqueous solution 1.59× 10−4 (Ref. 37) 3.80
Table 4. Experimental Values from Literature Obtained at Different Experimental Conditions for the Overall Equilibrium Reaction Constant
Ka
Temperature (◦C) Solvent pKa
35 Aqueous solution 6.31 (Ref. 26)
35 Aqueous solution 6.31 (Ref. 38)
35 Aqueous solution made to ionic strength 0.1 with NaCl 6.07 (Ref. 38)
35 Aqueous solution made to ionic strength 0.2 with NaCl 6.01 (Ref. 38)
40 Aqueous solution 6.30 (Ref. 26)
40 Aqueous solution made to ionic strength 0.1 with NaCl 6.05 (Ref. 38)
40 Aqueous solution made to ionic strength 0.2 with NaCl 6.00 (Ref. 38)
38 Phosphate buffer with sodium bicarbonate (ionic strength = 0.12) 6.09 (Ref. 39)
32.5 HCl and sodium bicarbonate mixture (made to ionic strength of 0.65 with NaCl) 5.94 (Ref. 31)
37 Isotonic solution (ionic strength = 0.154) 6.05 calculated
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Figure 1. Total buffer and bicarbonate buffer concentrations (mM) at physiologically relevant pH values as function of %CO2 in the solution
(100% = 1 atm) at 37◦C. Key ( ) 5% CO2; ( ) 10% CO2; ( ) 20% CO2; ( ) 40% CO2; ( ) 60% CO2.
equilibrium.
[
HCO−3
] = KaKHPCO2[
H+
] (8)
The values for PCO2 and [H
+] can be adjusted to yield a de-
sired bicarbonate buffer concentration. At low pH values, the
total buffer concentration, when CO2 (aq) concentration is in-
cluded, is relatively high due to high CO2 (g) partial pressures
found in vivo in the duodenum. Because of the solubility lim-
itations of carbon dioxide and the effect of [H+] on the con-
centration of bicarbonate, the presence of bicarbonate is most
significant for pH values in the range: 5.5 ≤ pH ≤ 7.5. For
pH below 5.5, only very dilute bicarbonate buffer concentra-
tions can be produced even at high CO2 (g) partial pressures.
At pH values above 7.5, only low CO2(g) values are required to
achieve relevant bicarbonate buffer concentrations though the
buffer capacity is substantially reduced. The relationship be-
tweenCO2 (g), CO2 (aq), [H+], and [HCO3−] is shown in Figure 1.
Typical physiologic conditions of pH and carbon dioxide levels
result in total buffer concentrations (CO2(aq) + [HCO3−]) in the
duodenum and jejunum in the range of 3–20 mM as shown in
Figure 1. Figure 1 also compares the total buffer concentration
to the bicarbonate concentration as a function of pH. The bicar-
bonate concentration present is significantly less than the total
buffer concentration especially at low pH values.
Simultaneous Diffusion and Reaction Model
Dissolution of drugs from a solid surface are generally accu-
rately predicted by considering the simultaneous diffusion and
chemical reactions as described by Mooney et al.1,40 Applying
this to a rotating disk dissolution apparatus permits the es-
timation of pH at the surface of a compacted drug by taking
into account the properties of the drug and buffer system and
assuming simultaneous and instantaneous diffusion and chem-
ical reaction in the hydrodynamic boundary layer near the sur-
face of the rotating disk. Levich characterized this boundary
layer thickness for a rotating disk based on liquid viscosity,
rotational speed, and diffusion coefficient41,42:
h= 1.61D1/3T−1/2v1/6 (9)
When the Levich theory is applied to rotating disk drug dis-
solution, h is the thickness of the diffusion layer, D is the diffu-
sion coefficient of the drug in the dissolving medium (aque-
ous buffer), L is the kinematic viscosity (at 37oC water =
0.007 cm2/s), and T is the rotational speed (100 rpm =
10.47 radians/s). The diffusion layer thickness is a constant for
each specific drug under fixed conditions of rotational speed
(see Table 5). Following Mooney et al.,1 the simultaneous
Table 5. The Effect Diffusion Layer Thickness (Ibuprofen Used for h
Calculation) has on the Time CO2 Spends in the Diffusion Layer (tD)
and How it Compares with the Reaction Time (tr = 6.25 s)
h (:m) tD tr/tD
61 (50 rpm) 0.76 8.2
43 (100 rpm) 0.38 16
27 (250 rpm) 0.15 42
19 (500 rpm) 0.076 82
14 (1000 rpm) 0.04 156
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diffusion and chemical reaction model assuming instantaneous
reaction was applied to the bicarbonate buffer system.
Applying a Simultaneous Diffusion and Reaction Model to
Bicarbonate Buffer
The reaction rate for the hydration of carbon dioxide to car-
bonic acid is a slow process as described above. If the time the
diffusing molecule spends in the diffusion layer is less than
the reaction time, then the reaction would primarily be occur-
ring only in the bulk solution and not in the diffusion layer.43
The average residence time of a molecule in the diffusion layer
is determined by diffusion layer thickness and the diffusivity
of the molecule43 (Eq. (10)). The reaction time depends on the
first order rate constant and it defines the time needed for the
reaction to be 63% complete43 (Eq. (11)). Equations (10) and
(11) can be used to assess the extent that a reaction will go to
completion within the diffusion layer:
tD = h
2
2Di
= 1.3v
1/3
D1/3i w
(10)
where tD is the average residence time of a diffusing molecule
in the diffusion layer. The reaction time, tr, is given by Eq. (11)
where k is the first order rate constant.
tr = 1k (11)
If the hydration reaction between CO2 (aq) and H2O does not
occur sufficiently fast, the reaction will not go to completion in
the diffusion layer and the flux of bicarbonate throughout the
diffusion layer will be less than predicted. Table 5 compares
the ratio of tr (∼6.25 s−1) and tD at different diffusion layer
thickness values (based on ibuprofen) calculated at different
rotational speeds. These values were calculated according to
the Levich equation for boundary layer thickness at the sur-
face of a rotating disk (Eq. (9)). The table shows that tr > tD
even at large diffusion layer thickness values (low rpm) and
that tr can vary between an order of magnitude to two orders
of magnitude greater than tD. This analysis indicates that the
hydration reaction is occurring to a very limited extent in the
diffusion layer, whereas the dehydration reaction appears suf-
ficiently fast that it may be assumed to be occurring rapidly
enough that these difference in reaction rates will impact the
buffer capacity of bicarbonate in the diffusion layer. It is worth
noting that these differences are relevant in the diffusion layer
but not in the bulk aqueous phase where all the reactions occur
sufficiently fast to be considered instantaneous and Reaction 5
and Ka apply.
As the results will show, this slow reaction has a large ef-
fect on the experimental flux in comparison with predictions
applying the instantaneous reaction filmmodel1 to bicarbonate
buffer. Initially, two different chemical equilibrium approaches
were applied. The first approach was to assume that all of the
reactions in the formation of bicarbonate buffer are sufficiently
fast so that the chemical equilibrium that is assumed to occur
in the bulk solution (and displayed in Reaction 5) can be ap-
plied to the boundary layer in the film model [pKa = 6.04; bulk
chemical equilibrium (BCE) model]. When applying the BCE
model, CO2 is the nonionized form of the buffer and HCO3− is
the ionized form of the buffer. The second approach assumed
that both the hydration reaction and dehydration reaction are
so slow in comparison with the ionization reactions that the
formation of bicarbonate is dependent only on Reaction 4 [pKa1
= 3.55, carbonic acid ionization (CAI) model]. In the case of
the CAI model, H2CO3 is the nonionized form of the buffer and
HCO3− is the ionized form. It is notable that the concentration
of CO2(aq) is 300 times greater than carbonic acid. Therefore,
the total buffer concentration used in the CAI model is less
than that used in the BCE model, which includes the CO2
(aq) concentration. However, the results show that these two
assumptions do not accurately describe experimental results.
Therefore, amodification to the transport analysis that incorpo-
rates the slow reaction rates for the hydration and dehydration
reactions is necessary.
Incorporating Reaction Rates into a Simultaneous Diffusion and
Chemical Reaction Model
The experimental results (see below) indicate that when re-
actions occur non-instantaneously, the film model needs to ac-
count for the slow reactions. There aremultiple species reacting
in the diffusion layer during the dissolution of a weak acid or
weak base drug, which makes adding reaction rates into the
film model challenging. Therefore, to follow the same steps us-
ing the simultaneous diffusion and chemical reaction model,
two assumptions were made to simplify the process. The first
assumption is that only the hydration and dehydration reac-
tion rates need to be considered and all other reactions can be
assumed to take place instantaneously. The second assumption
is that since the hydration reaction (kh) happens very slowly,
it can be assumed to not be taking place at all in the diffusion
layer (although it will occur in the bulk) and the only reaction
rate that needs to be included in the modeling process is the
dehydration reaction rate (kd). These assumptions describe a
situationwhere the protons formed at the surface of the dissolv-
ing weak acid drug will react with HCO3− to formH2CO3, which
can then form CO2 and H2O through an irreversible chemical
reaction (irreversible reaction model, IRR). This assumption,
when applied to the film model changes the resulting equation
for calculating the surface pH and the total buffer concentra-
tion does not include CO2 concentration. The surface pH is no
longer independent of reaction rates and diffusion layer thick-
ness because the dehydration reaction rate and diffusion layer
thickness remain included in the equation for surface pH. The
experimental results show that using the irreversible reaction
model (IRR model) allows for accurate predictions of drug flux
in bicarbonate buffer. The derivation of the IRR model is pre-
sented in the appendix and the cubic equation needed to solve
for surface pH and drug flux are shown in Appendix Eqs. (A34)
and (A35d).
MATERIALS AND METHODS
Ibuprofen (Albermarle - Baton Rouge, Louisiana, USA U;
Lot#11550–0005), indomethacin (Alexis Biochemicals - San
Diego, California USA; ≥98%, Lot#L25666, and ketoprofen
(Sigma–Aldrich - St. LouisMissouri, USA; Lot#044K0790)were
used as received and all other chemicals used were of analyti-
cal grade. Distilled water was used for all experiments. Mineral
oil United States Pharmacopeia (USP) grade was used for the
titration experiment to prevent the escape of CO2(g). All dis-
solution runs were performed in a jacketed beaker at 37◦C.
Two runs were done for each experimental condition described
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Table 6. Drug and Buffer Properties Applied to the Simultaneous Diffusion and Reaction Model
Species Solubility (M) pKa Diffusion Coefficient (cm2/s)
Ibuprofen 3.30 × 10−4 (Ref. 44) 4.43 (Ref. 44) 7.93 × 10−6a
Indomethacin 5.963 × 10−6b 4.27 (Ref. 45) 6.8 × 10−6 (Ref. 46)
Ketoprofen 5.303 × 10−4b 4.02 (Refs.47) 9.3 × 10−6 (Ref. 5)
Bulk bicarbonate 6.04b 14.6 × 10−6 (Ref. 48)
Carbonic acid 3.55 (Ref. 11) 14.6 × 10−6 (Ref.48)
Carbon dioxide 0.02403 24.9 × 10−6 (Ref. 49)
aEstimated using the Wilke–Chang equation.
bMeasured experimentally.
Other values were taken from literature.
below. Samples were analyzed using a UV spectrophotometer
(Agilent Technologies - Santa Clara, California, USA; Model#
61103A). The samples were obtained using a flow through sys-
tem that recycled the analyzed solution back into the dissolu-
tion vessel. The standard curves were also made using the UV
flow through system.
Ibuprofen solubility wasmeasured by agitating a suspension
of ibuprofen particles in 50 mM acetate buffer at pH 4.5 while
being kept at 37◦C. The pH of the saturated solution at 37◦C
was measured to be 4.5. Samples were taken from the solutions
and filtered before they were diluted with 50 mM acetate buffer
at pH 4.5. The measured solubility was 0.150 mg/mL and based
on the pH-solubility profile this solubility is in good agreement
with an intrinsic solubility of 0.068 mg/mL used in this paper
and reported by Karl et al.44
The intrinsic solubility of indomethacin was measured by
agitating a suspension of indomethacin particles in 0.1 N hy-
drochloric acid solution while being kept at 37◦C. Samples were
taken from the solutions and filtered before they were diluted
with 0.1 N hydrochloric acid.
The intrinsic solubility of ketoprofen was measured by agi-
tating a suspension of ketoprofen particles in 0.1 N hydrochlo-
ric acid solution while being kept at 37◦C. Samples were taken
from the solutions and filtered before they were diluted with
pH 6.7 25 mM phosphate buffer.
The pKa of the bicarbonate bufferwasmeasured by adjusting
100% dry compressed air and 100% carbon dioxide (at appro-
priate ratios to give physiologically relevant conditions) in a
100 mL 0.9%NaCl solution in a jacketed beaker at 37◦C. Solid
NaOH and a 5 N NaOH solution were used to adjust the buffer
pH to ∼7.0. Next, the sources of the gas mixture were elimi-
nated from the solution and USP grade mineral oil (heated to
37◦C) was added to the buffer solution where it produced an oil
layer on top of the aqueous buffer to limit the escape of carbon
dioxide gas. 1.0 M HCL solution was added in 0.1 mL incre-
ments to the aqueous phase and the pH was monitored until it
dropped to ∼5.0. In addition, the %CO2 in the aqueous phase
was monitored throughout using a CO2 monitor (YSI 8500 CO2
monitor - Yellow Springs, Ohio, USA).
For the dissolution experiments in bicarbonate buffer, dif-
ferent concentrations of bicarbonate buffer were prepared by
adjusting quantities of 100% dry compressed air and 100%
carbon dioxide in a 0.9%NaCl solution at appropriate ratios
to make physiologically relevant concentrations of bicarbon-
ate buffer. See Table 6 for the experimental parameters used
for the dissolution tests. The %CO2(aq) in solution was deter-
mined using a CO2 monitor (YSI 8500) and pH was monitored
using a pH meter (Beckman  40 - Brea, California, USA).
The mixture of carbon dioxide gas and air was continuously
pumped in throughout the dissolution runs to maintain bulk
equilibrium. Solid sodium hydroxide and sodium hydroxide so-
lution was added to adjust pH. The volume of the bicarbonate
buffer dissolution medium for ibuprofen and indomethacin was
100mL and for ketoprofen it was 200mL. Differences in volume
used for the experiments were made according to the solubility
and predicted flux of each drug to achieve desirable experimen-
tal conditions (sink conditions and adequate sensitivity for UV
analysis). All experiments were carried out at 100 rpm. How-
ever, dissolution tests for ibuprofen were also done at rotational
speeds of 50, 250, and 500 rpm. Ibuprofen was also performed
at bulk pH values 5.5, 6.0, and 7.0 (see Table 6 for buffer con-
centration at each pH).
The flux of the drug was predicted by applying the mathe-
matical models outlined in this paper and the parameters that
are given in Table 6 and7 usingMATLAB (MathWorks - Natick,
Massachusetts, USA).
RESULTS
Bicarbonate Buffer Measured pKa
Figure 2 shows the measured pH as a function of the amount
of 1.0 M HCl added during the titration and the experimen-
tal buffer capacity (dn/dpH) as a function of pH. This titra-
tion data suggest that the pKa of the bulk solution is ∼6.
A statistical analysis was performed by comparing the resid-
ual sum of squares and the result was a best fit bulk pKa
of 6.04. This value was used for calculating the bulk bi-
carbonate buffer concentrations for all of the rotating disk
dissolution experiments. Additionally, this was the pKa that
was used in the BCE model for predicting drug flux in bi-
carbonate buffer. One factor to note is that bicarbonate con-
centration is continuously changing throughout the titration
because the%CO2 increases as the pH decreases. However,
it was observed in the bulk solution that CO2 (aq) acts
as a buffer component and therefore the total buffer con-
centration remains relatively constant. The measured value
of 6.04 for the pKa of the overall reaction (Reaction 5)
is consistent with experimentally determined values in the lit-
erature (Table 4).
Ibuprofen Results
Figure 3 shows the predicted impact of rotational speed (change
in diffusion layer thickness) on the surface pH and the rel-
ative buffering ability of bicarbonate based on the differ-
ent model approaches for ibuprofen. Assuming instantaneous
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Table 7. Rotating Disk Dissolution Experimental Parameters Applied to the Weak Acid Drugs Examined
Drug Ibuprofen Indomethacin Ketoprofen
Bulk pH 5.5 6.0 6.5 7.0 6.5 6.5
Percent CO2 50 45 7–8, 14–16,a
21–22
5 7–8, 14–16, 21–22 7–8, 14–16, 24–26
Total buffer
concentration
[CO2(aq)]+[HCO3−]
(mM)
15.5 20.7 6.5–7.5, 13–15*,
19.5–20.5
12.2 6.5–7.5, 13–15,
19.5–20.5
6.5–7.5, 13–15, 22–24
Bicarbonate
concentration
[HCO3−] (mM)
3.5 9.9 5–5.5, 10–11,a
14.5–15.5
11 5–5.5, 10–11,
14.5–15.5
5–5.5, 10–11, 16.5–18.0
rpm 100 100 50, 100, 250, 500 100 100 100
aThe concentration used for the ibuprofen experiments at 50, 250, and 500 rpm. For ibuprofen at pH 6.5 and 100 rpm, all buffer concentrations listed were used.
Figure 2. Titration curve for a closed bicarbonate buffer system at 37◦C and isotonic ionic strength (0.154 M).
hydration/dehydration reactions (BCE model: pKa = 6.04) pre-
dicts bicarbonate to have the greatest buffer capacity and
highest surface pH. When it is assumed that the hydra-
tion/dehydration reactions do not occur at all in the diffusion
layer (CAI model: pKa 3.55), bicarbonate is predicted to have
a low buffer capacity and low predicted surface pH. Assuming
carbonic acid undergoes the irreversible dehydration reaction
(IRR model), the predictions of buffer capacity and surface pH
fall between the BCE and CAI models. Additionally, Figure 3
shows that the predicted surface pH decreases using the IRR
model as the rotational speed increases. The thickness of the
diffusion layer has no effect on surface pH for the BCE and
CAI models because it is assumed that chemical equilibrium is
achieved instantaneously in each case.
Figure 4 shows the experimental and predicted results for
the flux of ibuprofen in bicarbonate buffer at different rota-
tional speeds. As will be seen with all of the experimental data,
the BCE model overestimates the effect bicarbonate buffer has
on increasing the surface pH and the flux of ibuprofen. The
CAI model underestimates the effect of bicarbonate buffer and
the flux of ibuprofen. The flux predictions for the BCE and CAI
models in Figure 4 are influenced only by the changing diffu-
sion layer thickness as the rotational speed is changed because
the surface pH is constant and independent of diffusion layer
thickness (see Fig. 3). The predicted flux in the IRR model also
depends on diffusion layer thickness but in a more complicated
fashion. The surface pH is dependent on the residence time of
the diffusing species, H2CO3, and this impacts the consumption
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Figure 3. The predicted surface pH of ibuprofen in 10 mM bicarbonate buffer at pH 6.5 and different rotational speeds at 37◦C. Key ( )
BCE model predictions; ( ) IRR model predictions; ( ) CAI model predictions.
Figure 4. The experimental (50, 100, 250, and 500 rpm) and predicted flux of ibuprofen in 10 mM bicarbonate buffer ([HCO3−] only) at pH 6.5
and different rotational speeds at 37◦C. Key (•) experimental flux; ( ) BCE model flux predictions; ( ) IRR model flux predictions;
( ) CAI model flux predictions.
of H+ through the irreversible dehydration reaction (see Fig. 3
and Appendix Eq. 34). The IRR model more accurately predicts
the effect of a changing diffusion layer thickness as well as the
diffusing species residence time in the diffusion layer on the
ability of bicarbonate to buffer the pH at the surface of the
dissolving drug.
Figure 5 shows the predicted and experimental flux of
ibuprofen in bicarbonate buffer over a range of buffer
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Figure 5. The experimental and predicted flux of ibuprofen in bicarbonate buffer ([HCO3−] only) at multiple concentrations (at pH 6.5 and
37◦C). Key (•) experimental flux; ( ) BCE model flux predictions; ( ) IRR model flux predictions; ( ) CAI model flux predictions.
Figure 6. The experimental and predicted flux of ibuprofen in 10 mM bicarbonate buffer [HCO3−] only) at bulk pH values of 5.3(3.5 mMHCO3−),
6, 6.5, and 7 at 37◦C. Key (•) experimental flux; ( ) BCE model flux predictions; ( ) IRR model flux predictions; ( ) CAI model
flux predictions.
concentrations at pH 6.5. There is a large difference in flux pre-
dictions when comparing the BCE versus CAI models. The ex-
perimental flux of ibuprofen in bicarbonate buffer falls between
predictions assuming instantaneous hydration/dehydration re-
actions (BCE model) or no hydration/dehydration reactions
(CAI model). When the hydration reaction is assumed to not
occur and the dehydration reaction rate is incorporated into the
mathematical analysis (IRRmodel), the predicted flux matches
the experimental flux very well.
Figure 6 shows the effect bulk pH has on the flux of ibuprofen
in 10–11 mM bicarbonate buffer at pH values of 6, 6.5, and 7 as
well as 3.5 mM bicarbonate buffer at pH 5.5. The experimental
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Figure 7. The experimental and predicted flux of ketoprofen in bicarbonate buffer ([HCO3−] only) at multiple concentrations (at pH 6.5 and
37◦C). Key (•) experimental flux; ( ) BCE model flux predictions; ( ) IRR model flux predictions; ( ) CAI model flux predictions.
flux shows little variation as bulk solution pH is changed. The
BCE model overestimates the effect that bulk pH and bicar-
bonate buffer have on increasing the pH at the surface of the
dissolving drug and the flux of ibuprofen. The CAImodel under-
estimates the effect that bulk pH and bicarbonate buffer have
on increasing the pH at the surface of the dissolving drug and
the flux of ibuprofen. The flux of ibuprofen in bicarbonate buffer
over different bulk pH values is accurately predicted using the
IRR model.
Ketoprofen Results
Figure 7 shows the experimental and predicted flux of keto-
profen in bicarbonate buffer over a range of buffer concentra-
tions at pH 6.5. The predictions show that an increase in buffer
concentration results in a significant increase in the flux. In
comparison with ibuprofen, the solubility of ketoprofen is sim-
ilar but it has a lower drug pKa. Therefore, ketoprofen acts
as a similar self-buffer to ibuprofen but will be impacted by
increasing buffer concentrations more under the experimental
conditions. As was seen with ibuprofen, the experimental flux
of ketoprofen in bicarbonate buffer is not predicted accurately
by the BCE and CAI models and is only accurately predicted
when the dehydration reaction rate is incorporated by applying
the IRR model.
Indomethacin Results
Figure 8 shows the experimental and predicted flux of in-
domethacin in bicarbonate buffer over a range of buffer con-
centrations at pH 6.5. In comparison with ibuprofen and keto-
profen, the solubility of indomethacin is much lower. Therefore,
indomethacin does not serve as an effective self-buffer, which
leads to the surface pH approaching the bulk pH at low buffer
concentrations. As was seen for with the other weak acid drugs,
the experimental flux of indomethacin in bicarbonate buffer is
not predicted accurately by the BCE or CAI models and is only
accurately predicted by applying the IRR model.
To provide further confirmation for the accuracy of the IRR
model, previous experimental work involving rotating disk dis-
solution in bicarbonate buffer was evaluated. A specific exam-
ple is work by McNamara et al.10 that also looked at the weak
acid drug indomethacin using rotating disk dissolution. Their
work focused on dissolution at different bicarbonate buffer con-
centrations (different bulk PCO2 ) at a bulk pH of 6.8. Figure 9
shows that the IRRmodel gives accurate predictions for the flux
of indomethacin that was interpolated from the rotating disk
experiments of McNamara et al. (Fig. 3 in their paper) using
the parameters in Table 7 as well as the pKa for indomethacin
that was reported in their paper (pKa = 4.17).
DISCUSSION
The results show that the ability of bicarbonate to buffer the
surface pH of a dissolving drug is dependent on the hydra-
tion/dehydration reaction kinetics. The boundary layer IRR
model predicts the pH at the surface of the dissolving drug and
allows for accurate predictions of drug flux consistent with the
mass transport analysis. The success of the boundary layer IRR
model indicates that H2CO3 will form CO2 and H2O through an
irreversible reaction in the diffusion layer while undergoing its
instantaneous, reversible ionization reaction to form bicarbon-
ate. The IRR model, in effect, means that bicarbonate buffer
behaves differently at the solid surface and in the boundary
layer of a dissolving drug than it does in the bulk dissolution
medium where the hydration/dehydration reaction is at equi-
librium. In effect, bicarbonate has a “dynamic buffer capacity”
represented by the IRR model at the dissolving surface and
boundary layer where the hydration reaction can be assumed
to not occur while it has the standard buffer capacity expected
of bicarbonate buffer in the bulk.
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Figure 8. The experimental and predicted flux of indomethacin in bicarbonate buffer ([HCO3−] only) at multiple concentrations (at pH 6.5 and
37◦C). Key (•) experimental flux; ( ) BCE model flux predictions; ( ) IRR model flux predictions; ( ) CAI model flux predictions.
Figure 9. The experimental (data interpolated from Fig. 3 of McNamara et al.10) and predicted flux of indomethacin in bicarbonate buffer at
multiple concentrations (at pH 6.8 and 37◦C). Key (•) experimental flux; ( ) IRR model flux predictions based on indomethacin pKa =
4.17; ( ) IRR model flux predictions based on indomethacin pKa = 4.27.
Based on drug solubility and drug pKa, each drug studied
has a different self-buffering effect at its dissolving surface.
The results show that the IRR model accurately predicts sur-
face pH and drug flux even when large differences in drug
properties exist. For example, indomethacin has an intrinsic
solubility ∼100 times lower than ibuprofen and ketoprofen but
this does not impact the accuracy of the predictions. Addition-
ally, the ibuprofen and indomethacin data from this paper and
from McNamara et al. show the robustness of the IRR model to
changes in experimental conditions and the accuracy of the IRR
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model to be replicated in different laboratories. The IRR model
can accurately account for surface pH changes when the bulk
pH and diffusion layer thickness is altered. When the diffusion
layer thickness decreases, less time is available for the protons
that have formed H2CO3 to undergo the dehydration reaction
and form CO2 and H2O. This changes the ability of bicarbonate
to function as a buffer and it becomes similar to a situation
where only the ionization reaction occurs. Therefore, changing
the rotational speed of the disk will change the surface pH and
this can be well accounted for by the IRR model. The impact
on surface pH that results from the changing diffusion layer
thickness in the IRR model is one of the many factors taken
into account in the cubic equation (Appendix Eq. (34)) that cal-
culates the pH at the surface of the dissolving drug. The IRR
and the CAI models have different mass transfer coefficients
for the flux of carbonic acid. The mass transfer coefficient of
carbonic acid for the IRR model is
√
kdDH2CO3 and the mass
transfer coefficient for the CAI model is
DH2CO3
h . When the ratio
of the mass transfer coefficients equals one (h = 5.4 :m) then
the pH at the surface becomes equal to the CAI model because
the irreversible reaction is no longer consuming protons that
will allow for an increase in the buffer capacity beyond the CAI
model. Conversely, Figures 3 and 4 show that as the diffusion
layer thickness becomes larger, the proton consumption caused
by the irreversible chemical reaction increases, which allows
for the IRR model to provide a similar buffer effect that is seen
in the BCE model, However, this effect would only occur at
unrealistically large diffusion layer thickness values.
Although bicarbonate is the buffer present in the GI tract,
using it as a buffer in dissolution testing is challenging because
of long preparation times and hydrodynamic concerns (i.e.,
presence of air and CO2 gas bubbles in the apparatus) that
make it less than ideal. However, the accuracy of the IRR
model in predicting drug flux in bicarbonate buffer using known
physicochemical parameters allows for the possibility of pre-
dicting a more physiologically relevant buffer based on the
physicochemical properties of the drug. Aunins et al.3 demon-
strated that the dissolution of weak acid drugs can be accu-
rately predicted in standard buffers (i.e., phosphate) using the
standard film model. The accuracy of these models creates the
basis for the development of an in vitro dissolution buffer sys-
tem with more standard buffers that would be more predictive
of the in vivo buffer conditions. However, the work carried out
in this paper and by Aunins et al.3 applies only to rotating disk
dissolution with fixed experimental conditions in the bulk solu-
tion. A dissolving ionizable dosage form could have an effect on
the bulk pH or introduce additional ionic or buffering species
that could impact experimental and predicted dissolution rates.
Additionally, the dynamic nature of the in vivo environment
with dynamic intestinal secretion of bicarbonate, the absorp-
tion of water, and transit through the intestine continues to
make prediction of in vivo dissolution complex.
CONCLUSIONS
Applying the boundary layer model with the assumption of
instantaneous BCE (BCE model) does not accurately predict
the buffer capacity of bicarbonate in the diffusion layer of a
dissolving drug. Assuming that the hydration and dehydration
reactions happen instantaneously overestimates the ability of
bicarbonate to buffer the pH at the surface of the dissolving
drug. On the other hand, assuming that both the dehydration
and hydration reactions are too slow to occur in the diffusion
layer (CAI model) underestimates the impact of bicarbonate
buffer in the diffusion layer and at the surface of the tablet.
The predicted and experimental flux in bicarbonate buffer
indicates the importance of the reaction kinetics in the bicar-
bonate buffer system. The effect of the slow hydration reaction
in the diffusion layer has a significant impact on the buffer ca-
pacity of bicarbonate at the surface of a dissolving drug and
drug dissolution. The assumption that CO2 does not react with
H2O in the diffusional boundary layer, and thus assuming that
H2CO3 undergoes an irreversible chemical reaction forming
CO2 and H2O in addition to its ionization reaction (pKa =
3.55), accurately predicts the effect that bicarbonate buffer has
on the pH in the diffusion layer. The IRR model is interme-
diate between the BCE and CAI models and most accurately
describes the experimental results. In effect, bicarbonate has:
(a) a “dynamic buffer capacity” represented by the IRR model
at the dissolving surface where the hydration reaction can be
assumed to not occur and, (b) the standard buffer capacity ex-
pected of bicarbonate buffer in the bulk where the hydration
reaction can be assumed to occur sufficiently quickly to appear
to be instantaneous (i.e., is at equilibrium). The irreversible re-
action in the diffusion layer where H2CO3 forms CO2 and H2O
allows protons to be consumed and assists in buffering the pH
at the surface of the tablet. The protons consumed by the ir-
reversible reaction is a function of the time H2CO3 spends in
the diffusion boundary layer and is therefore dependent on the
thickness of the diffusion layer. Unlike the film models, assum-
ing instantaneous chemical equilibrium (BCE and CAI), the pH
at the surface in the IRR model is a function of diffusion layer
thickness.
The IRR model has been shown to accurately predict the
rotating disk dissolution rate of the weak acid drugs studied.
More experimental work is needed to assess its applicability
to weak bases and amphoteric drugs. However, for ionizable
drugs, the pH at the surface is a key component in determining
the rate at which the drug will dissolve, and the IRR model is
accurate at predicting surface pH under various experimental
conditions examined in this paper. Therefore, the IRR model
may be used to identify buffers that more closely resemble
the bicarbonate buffer of the luminal fluid and provide an ap-
proach for the development of more relevant in vivo dissolution
media.
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APPENDIX
Irreversible reaction (IRR) model for the dissolution of weak
acid drugs (HA = unionized form of the weak acid drug; A− =
ionized form of the weak acid drug) in bicarbonate buffer. Below
are the equilibrium reactions before the irreversible dehydra-
tion reaction assumption is introduced:
H+ +OH−
Kw
H2O
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HA
KAa
H+ + A−
HA+OH−
K∗1
H2O+ A−
HA+HCO−3
K2
H2CO3 + A−
CO2 +H2O
KC
H2CO3
H2CO3
Kal
HCO−3 +H+
CO2 +OH−ka2 HCO−3 is not considered because research has
shown that this reaction would not play a role at the pH the
experiments were performed at.50
Chemical equilibrium constant equations:
Kw =
[
H+
] [
OH−
]
(A1)
KAa =
[
A−
] [
H+
]
[
HA
] (A2)
K1 =
[
A−
]
[
HA
] [
OH−
] = KAa
KW
(A3)
K2 =
[
A−
] [
H2CO3
]
[
HA
] [
HCO−3
] = KAa
Ka1
(A4)
Kc =
[
H2CO3
]
[
CO2
] = kh
kd
(A5)
Ka1 =
[
HCO−3
] [
H+
]
[
H2CO3
] = ka1f
ka1r
(A6)
Differential equations defining the flux of the different
species:
*
[
HA
]
*t
= DHA
*2
[
HA
]
*X2
+ ∅1 = 0 (A7)
*
[
A−
]
*t
= DA
*2
[
A−
]
*X2
+ ∅2 = 0 (A8)
*
[
H+
]
*t
= DH
*2
[
H+
]
*X2
+ ∅3 = 0 (A9)
*
[
OH−
]
*t
= DOH
*2
[
OH−
]
*X2
+ ∅4 = 0 (A10)
*
[
HCO−3
]
*t
= DHCO3
*2
[
HCO−3
]
*X2
+ ∅5 = 0 (A11)
*
[
H2CO3
]
*t
= DH2CO3
*2
[
H2CO3
]
*X2
+ ∅6 = 0 (A12)
*
[
CO2
]
*t
= DCO2
*2
[
CO2
]
*X2
+ ∅7 = 0 (A13)
Defining ∅ 1–7 for the differential equations:
∅1 = −kAaf
[
HA
]+ kAar [H+] [A−]− k1f [HA] [OH−]
+k1r
[
A−
]− k2f [HA] [HCO−3 ]+k2r]H2CO3] [A−]
∅2 = kAaf
[
HA
]− kAar [H+] [A−]+ k1f [HA] [OH−]
−k1r
[
A−
]+K2f [HA] [HCO−3 ]− k2r [H2CO3] [A−]
∅3 = kAaf
[
HA
]− kAar [H+] [A−]+ ka1f [H2CO3]− ka1r [H+] [HCO−3 ]
∅4 = −k1f
[
HA
] [
OH−
]+ k1r [A−]
∅5 = −K2f
[
HA
] [
HCO−3
]+K2r [H2CO3] [A−]
+ka1f
[
H2CO3
]− ka1r [H+] [HCO−3 ]
∅6 = k2f
[
HA
] [
HCO−3
]− k2r [H2CO3] [A−]+ kh [CO2]
−kd
[
H2CO3
]− ka1f [H2CO3]+ ka1r [H+] [HCO−3 ]
∅7 = −kh
[
CO2
]+ kd [H2CO3]
Setting up relations for ∅ and the diffusion terms based on
assumptions from Mooney et al.1:
The first relation is that the amount of components reacting
as acids must equal the amount of components acting as bases.
∅4 + ∅5 = ∅1 + ∅3 (A14)
Equation (A14) based on the definitions for phi above:
(−k1f [HA][OH−]+ k1r[A−])+ (−k2f [HA][HCO−3 ]
+ k2r[H2CO3][A−]+ ka1f [H2CO3]− ka1r[H+][HCO−3 ])
= (−kAaf [HA]+KAar[H+][A−]− k1f [HA][OH−]+ k1r[A−]
−k2f [HA][HCO−3 ]+ k2r[H2CO3][A−])+ (kAaf [HA]
−kAar[H+][A−]+ ka1f [H2CO3]− ka1r[H+][HCO−3 ]) (A15)
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The like terms cancel on each side of the above equation
which leads to Eq. (A15) becoming: 0 = 0
The second assumption is that the acid drug in solution is
neither created nor destroyed.
∅1 + ∅2 = 0 (A16)
Equation (A16) based on the definitions for phi above:
0 = (−kAaf [HA]+ kAar[H+][A−]− k1f [HA][OH−]
+ k1r[A−]− k2f [HA][HCO−3 ]+ k2r[H2CO3][A−])
+ (kAaf [HA]− kAar[H+][A−]+ k1f [HA][OH−]
−k1r[A−]+ k2f [HA][HCO−3 ]− k2r[H2CO3][A−])
Equation (A16) allows for the relation made in Eq. (A17)
based on the assumption of steady state.
DHA
*2
[
HA
]
*X2
+DA
*2
[
A−
]
*X2
= 0 (A17)
The third assumption is that since kh is so small
(∼0.1–0.16 s−1) it is going to be assumed that it is not playing a
role in formation of any H2CO3 in the diffusion layer. Therefore,
H2CO3 is undergoing an irreversible chemical reaction to form
CO2 and H2O in addition to the reversible ionization reaction
that forms H+ and HCO3−. The change in carbon dioxide con-
centration has no effect on the other buffer components leading
to the IRR model.
CO2 (aq)+H2O
kd←H2CO3
K1→←H+ +HCO−3
Therefore, it is assumed that the only two buffer components
are H2CO3 and HCO3−. The change in bicarbonate is based only
upon the change in carbonic acid. This assumption leads to
Eq. (A18):
DHCO3
*2[HCO−3 ]
*X2
− k2f [HA][HCO−3 ]+ k2r[H2CO3][A−]
+ ka1f [H2CO3]− ka1r[H+][HCO−3 ]
= −
(
DH2CO3
*2[H2CO3]
*X2
+ k2f [HA][HCO−3 ]− k2r[H2CO3][A−]
− ka1f [H2CO3]+ ka1r[H+][HCO−3 ]− k[H2CO3]
)
(A18)
All of the like terms cancel and Eq. (A18) simplifies to
Eq. (A19).
DHCO3
*2
[
HCO−3
]
*X2
= −
(
DH2CO3
*2
[
H2CO3
]
*X2
− kd
[
H2CO3
])
(A19)
At this point, all of the second order differential equations
can be solved. For all of the terms that are diffusion con-
trolled, the boundary conditions and general solution are shown
below.
DC
*2 [C]
*X2
= 0 (A20)
Boundary conditions:
a tx = h;C = Ch
a tx = 0;C = C0
The general solution to the second order differential is shown
below.
c = (Ch − Co) x
h
+ C0 (A21)
H2CO3 is not only diffusion controlled because it also under-
goes an irreversible chemical reaction. The boundary conditions
are the same for the species but its general solution is different.
DH2CO3
*2
[
H2CO3
]
*X2
− kd
[
H2CO3
] = 0 (A22)
DH2CO3
*2
[
H2CO3
]
*X2
= kd
[
H2CO3
]
Boundary conditions:
a tx = h;C = [H2CO3]h
a tx = 0;C = [H2CO3]0
The general solution to the second order differential for car-
bonic acid is shown below.
⎛
⎝−[H2CO3]0e−
√
kd√
DH2CO3
h
+ [H2CO3]h
⎞
⎠ e
√
kd√
DH2CO3
x
e
√
kd√
DH2CO3
h
− e
−
√
kd√
DH2CO3
h
−
⎛
⎝[H2CO3]h − [H2CO3]0e
√
kd√
DH2CO3
h
⎞
⎠ e−
√
kd√
DH2CO3
x
e
√
kd√
DH2CO3
h
− e
−
√
kd√
DH2CO3
h
(A23a)
The diffusion coefficient of carbonic acid is a constant
(DH2CO3 = 14.6 × 10−6 cm2/s) and so is the dehydration rate
constant (kd = 50 s−1). The diffusion layer thickness changes
based on the Levich equation but it is on the order of 0.001–
0.005. Therefore, e
−
√
kd√
DH2CO3
h
is so small (∼4 × 10−5) in com-
parison with e
√
kd√
DH2CO3
h
(∼2.5 × 104) that it can be assumed
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that e
−
√
kd√
DH2CO3
h
and − [H2CO3]0 e−
√
kd√
DH2CO3
h
(∼ 10−7–10−9) and
[
H2CO3
]
h e
−
√
kd√
DH2CO3
h
(∼ 10−9–10−10) is equal to zero and equa-
tion (A23a) becomes Eq. (A23b).
[H2CO3]he
√
kd√
DH2CO3
x
e
√
kd√
DH2CO3
h
−
⎛
⎝[H2CO3]0e
√
kd√
DH2CO3
h
⎞
⎠ e−
√
kd√
DH2CO3
x
e
√
kd√
DH2CO3
h
(A23b)
In order to apply the rest of the assumptions to the film
model, the derivative to all of the general solutions must
be obtained in order to define all of the species in terms of
flux.
Taking the derivative of all of the diffusion controlled species
gives the equation below:
∂ [C]
∂X
= (Ch − Co)
h
(A24)
Equation (A24) must be multiplied by the diffusion coeffi-
cient to give the flux of the species.
D
∂ [C]
∂X
= D (Ch − Co)
h
(A25)
Taking the derivative of the general solution for H2CO3
(Eq. (A23b) gives Eq. (A26).
[H2CO3]h
√
kde
√
kd√
DH2CO3
x
√
DH2CO3e
√
kd√
DH2CO3
h
− [H2CO3]0
√
kde
−
√
kd√
DH2CO3
x
√
DH2CO3
(A26)
In order to solve for the flux from x = h to x = 0, the h and x
must be inserted into Eq. (A26).
At x = 0
[
H2CO3
]
h
√
kde
√
kd√
DH2CO3
0
√
DH2CO3e
√
kd√
DH2CO3
h
−
[
H2CO3
]
0
√
kde
−
√
kd√
DH2CO3
0
√
DH2CO3
(A27)
e
√
kd√
DH2CO3
0
is equal to 1 which simplifies the above equation:
[
H2CO3
]
h
√
kd
√
DH2CO3e
√
kd√
DH2CO3
h
−
[
H2CO3
]
0
√
kd√
DH2CO3
√
DH2CO3 e
√
kd√
DH2CO3
h
(∼0.4)  [H2CO3]h √kd (∼10−4–10−5)
that [
H2CO3]h
√
kd
√
DH2CO3 e
√
kd√
DH2CO3
h
is considered to be zero which leaves:
−
[
H2CO3
]
0
√
kd√
DH2CO3
At x = h
[
H2CO3
]
h
√
kde
√
kd√
DH2CO3
h
√
DH2CO3e
√
kd√
DH2CO3
h
−
[
H2CO3
]
0
√
kde
−
√
kd√
DH2CO3
h
√
DH2CO3
e
−
√
kd√
DH2CO3
h
is so small (∼4 × 10−5) that it can be assumed
that it and − [H2CO3]0 √kde−
√
kd√
DH2CO3
h
= 0
[
H2CO3
]
h
√
kd√
DH2CO3
Therefore ∂[H2CO3]
∂x from x = h (bulk solution) to the surface
of the tablet (x = 0) is
∂
[
H2CO3
]
∂x
=
√
kd√
DH2CO3
([
H2CO3
]
h −
[
H2CO3
]
0
)
(A28)
If you multiply each side by the diffusion coefficient of car-
bonic acid, then that will give the flux of carbonic acid.
DH2CO3
∂
[
H2CO3
]
∂x
= ([H2CO3]h − [H2CO3]0)
√
DH2CO3kd (A29)
It is assumed that electric neutrality is maintained at every
point in the diffusion layer so the positively charged species
flux must be equal to the negatively charged species flux.∑
ziJi = 0 (A30)
DH
([
H+
]
h −
[
H+
]
0
)
h
= DOH
([
OH−
]
h −
[
OH−
]
0
)
h
+ DA
([
A−
]
h −
[
A−
]
0
)
h
+DHCO3
([
HCO−3
]
h −
[
HCO−3
]
0
)
h
(A31)
Another assumption is that since no boundary or internal
sources of buffer exist, then the total buffer flux must be equal
to 0.
DHCO3
([
HCO−3
]
h −
[
HCO−3
]
0
)
h
+ ([H2CO3]h − [H2CO3]0)
√
DH2CO3kd = 0 (A32)
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DHCO3
([
HCO−3
]
h −
[
HCO−3
]
0
)
h
= − ([H2CO3]h − [H2CO3]0)
√
DH2CO3kd (A33)
Equation (33) can be used to find the concentration of bicar-
bonate at the surface of the tablet. First it must be put in terms
of known values and H+ at the surface of the tablet as shown
below.
DHCO3
([
HCO−3
]
h −
[
HCO−3
]
0
)
= − ([H2CO3]h − [H2CO3]0)h
√
DH2CO3kd
−DHCO3
[
HCO−3
]
0 −
[
H2CO3
]
0
(
h
√
DH2CO3kd
)
= − [H2CO3]h (h
√
DH2CO3kd
)
−DHCO3
[
HCO−3
]
h
[
H2CO3
]
0 =
[
HCO−3
]
0
[
H+
]
0
Ka1
DHCO3
[
HCO−3
]
0 +
[
HCO−3
]
0
[
H+
]
0
Ka1
(
h
√
DH2CO3kd
)
= [H2CO3]h (h
√
DH2CO3kd
)
+DHCO3
[
HCO−3
]
h
[
HCO−3
]
0
(
Ka1DHCO3 +
[
H+
]
0
(
h
√
DH2CO3kd
))
= Ka1
([
H2CO3
]
h
(
h
√
DH2CO3kd
)
+DHCO3
[
HCO−3
]
h
)
[
HCO−3
]
0 =
Ka1
([
H2CO3
]
h
(
h
√
DH2CO3kd
)+DHCO3 [HCO−3 ]h)(
Ka1DHCO3 +
[
H+
]
0
(
h
√
DH2CO3kd
))
The above equation can be inserted into Eq. (A31) where
electric neutrality is assumed in the diffusion layer.
DH
([H+]h − [H+]0)
h
= DOH ([OH
−]h − [OH−]0)
h
+DA ([A
−]h − [A−]0)
h
+DHCO3
h
([
HCO−3
]
h
−
(
Ka1
([
H2CO3
]
h
(
h
√
DH2CO3kd
)+DHCO3 [HCO−3 ]h)(
Ka1DHCO3 +
[
H+
]
0
(
h
√
DH2CO3kd
))
))
(A31b)
The chemical equilibrium in Eqs. (A1) and (A2) was used to
define all of the species at the surface of the tablet (x = 0) in
either terms of
[
H+
]
0 or
[
HA
]
0.
DH
([H+]h − [H+]0)
h
= DOH
h
(
[OH−]h − Kw[H+]0
)
+ DA
h
(
[A−]h − [HA]0K
A
a
[H+]0
)
+DHCO3
h
([
HCO−3
]
h
−
(
Ka1
([
H2CO3
]
h
(
h
√
DH2CO3kd
)+DHCO3 [HCO−3 ]h)(
Ka1DHCO3 +
[
H+
]
0
(
h
√
DH2CO3kd
))
))
(A31c)
The pH at the surface can be calculated by applying the
boundary conditions to equation (31C).
Boundary conditions at X = h (bulk solution):
[
HA
] = [HA]h ∼= 0
[
A−
] = [A−]h ∼= 0
[
H+
] = [H+]h (known) = bulk pH
[
OH−
] = [OH−]h (known)
= known based on bulk pH and chemical equilibrium
[
HCO−3
] = [HCO−3 ]h (known) = experimental buffer
concentration
[
H2CO3
] = [H2CO3]h (known) = experimental buffer
concentration
[
CO2
] = [CO2]h (known) = analyzed with a CO2
monitor
Boundary conditions at X = 0 (surface of the drug):
[
HA
] = [HA]0 (Weak acid intrinsic Solubility)
[
A−
] = [A−]0 (unknown)
[
H+
] = [H+]0 (unknown)
[
OH−
] = [OH−]0 (unknown)
[
HCO−3
] = [HCO−3 ]0 (unknown)
[
H2CO3
] = [H2CO3]0 (unknown)
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[
CO2
] = [CO2]0 (unknown)
DH
(
[H+]h − [H+]0
)
h
= DOH
h
(
[OH−]h − Kw[H+]0
)
+ DA
h
(
− [HA]0K
A
a )
[H+]0
)
+DHCO3
h
([
HCO−3
]
h
−
(
Ka1
([
H2CO3
]
h
(
h
√
DH2CO3kd
)+DHCO3 [HCO−3 ]h)(
Ka1DHCO3 +
[
H+
]
0
(
h
√
DH2CO3kd
))
))
(A31d)
Multiplying Eq. (A31d) by h and subtracting the left side of
the equation from the right side results in the following cubic
equation to solve for
[
H+
]
0.
p
[
H+
]3
0 + q
[
H+
]2
0 + r
[
H+
]
0 + s= 0 (A34)
p = DH
(
h
√
DH2CO3Kd
)
q= −DH
[
H+
]
h
(
h
√
DH2CO3Kd
)+DOH [OH−]h (h√DH2CO3Kd)
+DHCO3
[
HCO−3
]
h
(
h
√
DH2CO3Kd
)+ Ka1DHCO3DH
r = −Ka1DHCO3DH[H+]h +Ka1DHCO3DOH[OH−]h
− DOHKw
(
h
√
DH2CO3Kd
)−DA[HA]0KAa (h√DH2CO3Kd)
− D2HCO3Ka1
[
HCO−3
]
h −DHCO3[H2CO3]hKa1
(
h
√
DH2CO3Kd
)
+ D2HCO3Ka1
[
HCO−3
]
h
s= −Ka1DHCO3DOHKw − Ka1DHCO3DA
[
HA
]
0 K
A
a
The total drug flux is dependent on the interfacial pH.
DHA
([
HA
]
h −
[
HA
]
0
)
h
+DA
([
A−
]
h −
[
A−
]
0
)
h
= total drug flux
(A35a)
[
HA
] = [HA]h ∼= 0
[
A−
] = [A−]h ∼= 0
DHA
− [HA]0
h
+DA
− [A−]0
h
= total drug flux (A35b)
DHA
− [HA]0
h
− DA
h
[
HA
]
0 K
A
a[
H+
]
0
= total drug flux (A35c)
Assuming the diffusion coefficient of the ionized form of
the drug is equal to the unionized form of the drug simplifies
Eq. (35c) to Eq. (35d).
−DHA
[
HA
]
0
h
(
1+ K
A
a[
H+
]
0
)
= total drug flux (A35d)
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